Login to Your Account

Three drug developers leap into the public market

Just weeks after the close of a flush third quarter for biotech fundraising, three more drug developers – Apellis Pharmaceuticals Inc., Inflarx NV and Genprex Inc. – are making the leap into the public market with IPOs, all on Nasdaq. more »

Our Habitat for All Things Science
Alternate circuit may yield obesity, cachexia targets

Partners in Focus